NovoCure Limited (NVCR) Profit Margins
Over the twelve months to 2026-06-30, NovoCure Limited (NVCR) had gross margin 76.1%, operating margin -22.1%, net margin -21.2%, free cash flow margin -3.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NVCRNovoCure LimitedFollow NVCR — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 37.7% | 44.2% | 68.6% | 67.7% | 74.8% | 78.5% | 78.5% | 78.6% | 74.8% | 77.3% | 74.5% | 76.1% | |
| Operating margin | -314.3% | -139.1% | -22.2% | -13.6% | -0.3% | 6.1% | -8.3% | -16.6% | -45.7% | -28.2% | -23.5% | -22.1% | |
| Net margin | -337.2% | -159.1% | -34.8% | -25.6% | -2.1% | 4.0% | -10.9% | -17.2% | -40.6% | -27.9% | -20.8% | -21.2% | |
| FCF margin | -316.0% | -136.6% | -22.9% | -3.5% | 4.6% | 17.0% | 11.0% | 1.8% | -19.7% | -11.4% | -11.5% | -3.6% |
USD billions · SEC XBRL
NovoCure Limited — questions
- What is NovoCure Limited's gross margin?
- 76.1% over the twelve months to 2026-06-30.
- What is NovoCure Limited's operating margin?
- -22.1% over the twelve months to 2026-06-30.
- What is NovoCure Limited's net profit margin?
- -21.2% over the twelve months to 2026-06-30.
Every figure on this page comes from NovoCure Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.